![Philip Donenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Donenberg
Director/Board Member at
TAYSHA GENE THERAPIES, INC.
Net worth: 1 M $ as of 31/05/2026
Profile
Philip B. Donenberg is currently Director at Sensei Biotherapeutics, Inc. since 2026, Independent Director at Taysha Gene Therapies, Inc. since 2020, and Independent Director at Tectonic Therapeutic, Inc. since 2024.
Former roles include Independent Director at AVROBIO, Inc., Controller at Unimed Pharmaceuticals LLC from 1995 to 1998, Chief Financial Officer & Senior Vice President at Assertio Therapeutics, Inc. in 2018, Chief Financial Officer, Secretary & Senior VP at ANI Pharmaceuticals, Inc. from 2011 to 2013, Controller at Applied NeuroSolutions, Inc., Controller at Molecular Geriatrics Corp from 1993 to 1994, Controller at Xtramedics, Inc., Controller at Gynex Pharmaceuticals, Inc., Chief Financial Officer at 7wire Ventures LLC from 2013 to 2014, Chief Financial Officer & Secretary at RestorGenex Corp.
from 2015 to 2016, Chief Financial Officer at Diffusion Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President at Jaguar Gene Therapy LLC from 2020 to 2023, and Chief Financial Officer & Senior Vice President at Novartis Gene Therapies, Inc. from 2017 to 2018.
Education includes undergraduate studies at the University of Illinois At Urbana–Champaign.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/06/2026 | 241,289 ( 0.09% ) | 1 M $ | 31/05/2026 | |
0% | 09/06/2026 | 166 ( 0% ) | 5 173 $ | 31/05/2026 |
| 10/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Philip Donenberg active positions
| Companies | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 31/08/2020 |
| SENSEI BIOTHERAPEUTICS, INC. | Director/Board Member | 13/02/2026 |
Former positions of Philip Donenberg
| Companies | Position | End |
|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Director of Finance/CFO | 01/03/2023 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director of Finance/CFO | 30/11/2018 |
| AVEXIS INC | Director of Finance/CFO | 01/07/2018 |
| DIFFUSION PHARMA | Director of Finance/CFO | 01/09/2016 |
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Director of Finance/CFO | 08/01/2016 |
Training of Philip Donenberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Unimed Pharmaceuticals LLC
 Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ANI Pharmaceuticals, Inc.
 ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Researches and develops pharmaceuticals | Health Technology |
Molecular Geriatrics Corp
 Molecular Geriatrics Corp Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products for the treatment and detection of Alzheimers and cancer | Commercial Services |
Xtramedics, Inc.
 Xtramedics, Inc. Household/Personal CareConsumer Non-Durables Feminine hygiene products | Consumer Non-Durables |
Gynex Pharmaceuticals, Inc.
 Gynex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
7wire Ventures LLC
 7wire Ventures LLC Investment ManagersFinance 7wire Ventures invests in companies located in the United States. The firm targets companies operating in the field of the healthcare sector. It provides financing for early and later stage capital requirements. | Finance |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapies | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Health Services |
- Stock Market
- Insiders
- Philip Donenberg
